
Transvaginal Mesh Compared With Native Tissue Repair for Pelvic Organ Prolapse
Author(s) -
Bruce S. Kahn,
R. Edward Varner,
Miles Murphy,
Peter K. Sand,
Stacy K. Thomas,
Lioudmila Lipetskaia,
Doreen E. Chung,
Ayman Mahdy,
Karen Noblett
Publication year - 2022
Publication title -
obstetrics and gynecology (new york. 1953. online)/obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.664
H-Index - 220
eISSN - 1873-233X
pISSN - 0029-7844
DOI - 10.1097/aog.0000000000004794
Subject(s) - medicine , clinical endpoint , surgery , surgical mesh , native tissue , propensity score matching , prospective cohort study , pelvic floor , randomized controlled trial , hernia , biomedical engineering , tissue engineering
To compare the safety and effectiveness of transvaginal mesh repair and native tissue repair, in response to a U.S. Food and Drug Administration (FDA) 522 study order to assess co-primary endpoints of superiority and noninferiority.